| Dr Darryl G Moffett Jr, MD | |
|
3544 E 17th St, Suite 105, Ammon, ID 83406-6911 | |
| (208) 535-4900 | |
| (208) 535-4906 |
| Full Name | Dr Darryl G Moffett Jr |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 37 Years |
| Location | 3544 E 17th St, Ammon, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003858465 | NPI | - | NPPES |
| 002726100 | Medicaid | ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | M-6263 (Idaho) | Primary |
| Entity Name | Teton Retinal Institute Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437274057 PECOS PAC ID: 7113069089 Enrollment ID: O20100115000499 |
News Archive
Covidien, a leading global provider of healthcare products, announced the results of an analysis that will be presented at the American College of Rheumatology's Annual Scientific Meeting. A pooled analysis of safety data suggests that patients with knee osteoarthritis (OA) receiving the topical PENNSAID® (diclofenac sodium topical solution) 1.5% w/w had significantly fewer gastrointestinal (GI)-related adverse events than those receiving an oral non-steroidal anti-inflammatory drug (NSAID).
The Detroit News: On Wednesday, "[a] federal judge heard arguments [in the] lawsuit that is being watched nationwide for its challenge of congressional authority to reform health care in a way that would penalize citizens who fail to obtain their own health insurance." The attorney for one plaintiff, The Thomas More Law Center, a group espousing religious principles, said, "There is no precedent for this power grab" (Guthrie, 7/22).
Officials from the U.S., African Union and the international community "are working with Sudan's government to open humanitarian access to" the country's Southern Kordofan and Blue Nile states, where refugees "fleeing fighting between local militia and government troops" have gathered and are in need of food aid, VOA News reports.
OncoVista Innovative Therapies, Inc., reported that the AdnaTest BreastCancer Select & Detect kit, manufactured by AdnaGen AG (Langenhagen, Germany), is now available for research as well as for pay-out-of-pocket patients in the Czech Republic and Slovakia.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Darryl G Moffett Jr, MD 3544 E 17th St, Suite 105, Ammon, ID 83406-6911 Ph: (208) 535-4900 | Dr Darryl G Moffett Jr, MD 3544 E 17th St, Suite 105, Ammon, ID 83406-6911 Ph: (208) 535-4900 |
News Archive
Covidien, a leading global provider of healthcare products, announced the results of an analysis that will be presented at the American College of Rheumatology's Annual Scientific Meeting. A pooled analysis of safety data suggests that patients with knee osteoarthritis (OA) receiving the topical PENNSAID® (diclofenac sodium topical solution) 1.5% w/w had significantly fewer gastrointestinal (GI)-related adverse events than those receiving an oral non-steroidal anti-inflammatory drug (NSAID).
The Detroit News: On Wednesday, "[a] federal judge heard arguments [in the] lawsuit that is being watched nationwide for its challenge of congressional authority to reform health care in a way that would penalize citizens who fail to obtain their own health insurance." The attorney for one plaintiff, The Thomas More Law Center, a group espousing religious principles, said, "There is no precedent for this power grab" (Guthrie, 7/22).
Officials from the U.S., African Union and the international community "are working with Sudan's government to open humanitarian access to" the country's Southern Kordofan and Blue Nile states, where refugees "fleeing fighting between local militia and government troops" have gathered and are in need of food aid, VOA News reports.
OncoVista Innovative Therapies, Inc., reported that the AdnaTest BreastCancer Select & Detect kit, manufactured by AdnaGen AG (Langenhagen, Germany), is now available for research as well as for pay-out-of-pocket patients in the Czech Republic and Slovakia.
› Verified 1 days ago